Nuclear JAK2

Blood

Volumn 118, Issue 26, 2011, Pages 6987-6988

  Dawson, Mark A ^a,b   Bannister, Andrew J ^b   Saunders, Lindsay ^c   Wahab, Omar Abdel ^c   Liu, Fan ^c   Nimer, Stephen D ^c   Levine, Ross L ^c   Göttgens, Berthold ^d   Kouzarides, Tony ^b   Green, Anthony R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2;

CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOPLASM; HEMATOPOIESIS; IMMUNOFLUORESCENCE; LETTER; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN STRUCTURE; WESTERN BLOTTING;

EID: 84455180406     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-385278     Document Type: Letter

References (15)

1. Girodon F, Steinkamp MP, Cleyrat C, Hermouet S, Wilson BS. Confocal imaging studies cast doubt on nuclear localization of JAK2V617F. Blood. 2011; 118(9):2633-2634.
2. Dawson MA, Bannister AJ, Gottgens B, et al. JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature. 2009;461(7265):819-822.
3. Griffiths DS, Li J, Dawson MA, et al. LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease. Nat Cell Biol. 2011;13(1):13-21.
4. Kamakura S, Oishi K, Yoshimatsu T, Nakafuku M, Masuyama N, Gotoh Y. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol. 2004;6(6):547-554. (Pubitemid 38786598)
5. Liu F, Zhao X, Perna F, et al. JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. Cancer Cell. 2011;19(2):283-294.
6. Lobie PE, Ronsin B, Silvennoinen O, Haldosen LA, Norstedt G, Morel G. Constitutive nuclear localization of Janus kinases 1 and 2. Endocrinology. 1996; 137(9):4037-4045. (Pubitemid 26284681)
7. Nilsson J, Bjursell G, Kannius-Janson M. Nuclear Jak2 and transcription factor NF1-C2: a novel mechanism of prolactin signaling in mammary epithelial cells. Mol Cell Biol. 2006;26(15):5663-5674. (Pubitemid 44134324)
8. Noon-Song EN, Ahmed CM, Dabelic R, Canton J, Johnson HM. Controlling nuclear JAKs and STATs for specific gene activation by IFNgamma. Biochem Biophys Res Commun. 2011;410(3):648-653.
9. Lefrancois-Martinez AM, Blondet-Trichard A, Binart N, et al. Transcriptional Control of Adrenal Steroidogenesis: novel connection between JAK2 and PKA through stabilization of transcription factor CREB. J Biol Chem. 2011;286(38): 32976-32985.
10. Lee S, Duhe RJ. Kinase activity and subcellular distribution of a chimeric green fluorescent protein-tagged Janus kinase 2. J Biomed Sci. 2006;13(6):773-786. (Pubitemid 44900650)
11. Jarvik JW, Telmer CA. Epitope tagging. Annu Rev Genet. 1998;32:601-618. (Pubitemid 29045326)
12. Qian CJ, Yao J, Si JM. Nuclear JAK2: Form and Function in Cancer. [published online ahead of print August 1, 2011]. Anat Rec (Hoboken). doi:10.1002/ ar.21443.
13. Zouein FA, Duhe RJ, Booz GW. JAKs go nuclear: Emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth. Growth Factors. 2011; 29(6):245-252.
14. Rui L, Emre NC, Kruhlak MJ, et al. Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell. 2010;18(6):590-605.
15. Baek SH. When signaling kinases meet histones and histone modifiers in the nucleus. Mol Cell. 2011;42(3):274-284.